Lexaria Bioscience (LEXX) Leases (2020 - 2026)
Lexaria Bioscience's Leases history spans 7 years, with the latest figure at $92018.0 for Q1 2026.
- Quarterly results put Leases at $92018.0 for Q1 2026, down 24.0% from a year ago — trailing twelve months through Feb 2026 was $92018.0 (down 24.0% YoY), and the annual figure for FY2025 was $106816.0, down 20.78%.
- Leases for Q1 2026 was $92018.0 at Lexaria Bioscience, down from $99485.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $178127.0 in Q2 2023 to a low of $32047.0 in Q1 2023.
- The 5-year median for Leases is $114015.0 (2025), against an average of $109001.8.
- The sharpest move saw Leases tumbled 55.55% in 2023, then surged 368.05% in 2024.
- Year by year, Leases stood at $42340.0 in 2022, then soared by 269.78% to $156565.0 in 2023, then decreased by 18.23% to $128025.0 in 2024, then fell by 22.29% to $99485.0 in 2025, then dropped by 7.51% to $92018.0 in 2026.
- According to Business Quant data, Leases over the past three periods came in at $92018.0, $99485.0, and $106816.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.